Staci is the Senior Vice President and Chief IP Counsel for Teva Pharmaceuticals, and has been in this role since 2013. She and her global team are responsible for all of Teva’s IP and regulatory law support for its specialty, generic, biologic/biosimilar, and API products. Stacie has been with Teva since 2004, previously serving in various IP roles. Prior to joining Teva, she was an associate at Fish & Neave. In 2015, Staci was named an Emerging Pharma Leader by Pharm Exec magazine. She received a BA in Chemistry from the University of Delaware and a JD from Georgetown University Law Center.